It has been demonstrated in animal models of AD that the endotoxin lipopolysaccharide (LPS) promotes both inflammation and the accumulation of p-Tau [24] and that suppression of microglial activity prolongs survival in FTDP-associated P301L transgenic mice [25]. The gene discussed is MAPT; the disease is Alzheimer disease.